These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

241 related items for PubMed ID: 1422616

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Clomipramine treatment of childhood obsessive-compulsive disorder. A double-blind controlled study.
    Flament MF, Rapoport JL, Berg CJ, Sceery W, Kilts C, Mellström B, Linnoila M.
    Arch Gen Psychiatry; 1985 Oct; 42(10):977-83. PubMed ID: 3899048
    [Abstract] [Full Text] [Related]

  • 4. Fluoxetine treatment of obsessive-compulsive disorder.
    Solyom L, Solyom C, Ledwidge B.
    Can J Psychiatry; 1991 Dec; 36(10):723-7. PubMed ID: 1790516
    [Abstract] [Full Text] [Related]

  • 5. Clomipramine treatment of obsessive-compulsive disorder. I. A controlled clinical trial.
    Thorén P, Asberg M, Cronholm B, Jörnestedt L, Träskman L.
    Arch Gen Psychiatry; 1980 Nov; 37(11):1281-5. PubMed ID: 7436690
    [Abstract] [Full Text] [Related]

  • 6. Return of symptoms after discontinuation of clomipramine in patients with obsessive-compulsive disorder.
    Pato MT, Zohar-Kadouch R, Zohar J, Murphy DL.
    Am J Psychiatry; 1988 Dec; 145(12):1521-5. PubMed ID: 3057923
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Venlafaxine versus clomipramine in the treatment of obsessive-compulsive disorder: a preliminary single-blind, 12-week, controlled study.
    Albert U, Aguglia E, Maina G, Bogetto F.
    J Clin Psychiatry; 2002 Nov; 63(11):1004-9. PubMed ID: 12444814
    [Abstract] [Full Text] [Related]

  • 9. Predictors of treatment response in obsessive-compulsive disorder: multivariate analyses from a multicenter trial of clomipramine.
    Ackerman DL, Greenland S, Bystritsky A, Morgenstern H, Katz RJ.
    J Clin Psychopharmacol; 1994 Aug; 14(4):247-54. PubMed ID: 7962680
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Obsessive-compulsive disorder: a double-blind, placebo-controlled trial of clomipramine in 27 patients.
    Jenike MA, Baer L, Summergrad P, Weilburg JB, Holland A, Seymour R.
    Am J Psychiatry; 1989 Oct; 146(10):1328-30. PubMed ID: 2675643
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Double-blind comparative study of clomipramine and amitriptyline in obsessive neurosis.
    Ananth J, Pecknold JC, van den Steen N, Engelsmann F.
    Prog Neuropsychopharmacol; 1981 Oct; 5(3):257-62. PubMed ID: 7022517
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Treatment of obsessive-compulsive disorder with clomipramine and desipramine in children and adolescents. A double-blind crossover comparison.
    Leonard HL, Swedo SE, Rapoport JL, Koby EV, Lenane MC, Cheslow DL, Hamburger SD.
    Arch Gen Psychiatry; 1989 Dec; 46(12):1088-92. PubMed ID: 2686576
    [Abstract] [Full Text] [Related]

  • 17. A predictive study of obsessive-compulsive disorder response to clomipramine.
    Alarcon RD, Libb JW, Spitler D.
    J Clin Psychopharmacol; 1993 Jun; 13(3):210-3. PubMed ID: 8354737
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.